The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 12, 2019

Filed:

Jul. 03, 2013
Applicants:

Utkan Demirci, Cambridge, MA (US);

Fatih Inci, Cambridge, MA (US);

Inventors:

Utkan Demirci, Cambridge, MA (US);

Fatih Inci, Cambridge, MA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 21/65 (2006.01); G01N 21/00 (2006.01); G01N 21/552 (2014.01); G01N 33/543 (2006.01); B01L 3/00 (2006.01); G01N 33/569 (2006.01); B82Y 15/00 (2011.01); C07K 17/14 (2006.01); G01N 33/53 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
G01N 33/56988 (2013.01); B82Y 15/00 (2013.01); C07K 17/14 (2013.01); G01N 21/554 (2013.01); G01N 33/5308 (2013.01); G01N 33/54346 (2013.01); G01N 33/54373 (2013.01); G01N 33/56916 (2013.01); G01N 33/6866 (2013.01); G01N 2333/16 (2013.01); G01N 2469/10 (2013.01);
Abstract

A nanoplasmonic platform can be used for the detection and quantification of multiple HIV subtypes in whole blood with localized surface plasmon resonance. Among other things, this nanoplasmonic platform provides a viable way to detection and quantification of viral load at a point of care with significantly less cost, time, and laboratory resources than existing methods of detection. Although an example of HIV detection in whole blood is provided, the nanoplasmonic platform is adaptable to detect other pathogens and infectious agents or macromolecules.


Find Patent Forward Citations

Loading…